The mixed race middle-aged woman has been in remission and free of HIV for 14 months and that too without the need for potent treatments known as antiretrovial therapy.
FDA Approves New Drug for Yeast Infection
June 3, 2021 The FDA has approved a new drug for vaginal yeast infections, something 3 out of every 4 women encounter at least once in their life.
Ibrexafungerp is the first drug approved in a new antifungal class for the condition, in more than 20 years, the drug s manufacturer Scynexis said in a press release. It is the first drug that does not use a type of antifungal known as azoles to treat vaginal yeast infections.
The company said approval came after positive results from two phase III studies in which an oral version of the drug showed efficacy and tolerability. The most common reactions observed in clinical trials were diarrhea, nausea, abdominal pain, dizziness, and vomiting.